CVLB News and Press, Conversion Labs Inc From 07/29/20

NEW YORK, July 29, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc.  (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, will hold a conference call on Monday, August 17, 2020 at 1:00 p.m. Eastern time to discuss its results for the second quarter ended June 30, 2020....

Conversion Labs ( OTCQB:CVLB -17.1% ) expects Q2 revenues of ~$9.2M, up 114% sequentially and 241% Y/Y, primarily driven by customer acquisitions and growth in subscription revenue generated by expanding portfolio of telemedicine, online pharmacy, and wellness brands. More news on: Con...

NEW YORK, July 07, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc.  (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, reported preliminary unaudited results for its second quarter ended June 30, 2020. Revenues totaled approximately $9.2 million, up 114% sequentiall...

NEW YORK, June 16, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc.  (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has appointed noted expert in internal medicine, Dr. Jeff Toll , to its medical advisory board .   As an industry thought-lead...

NEW YORK, June 09, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc.  (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, reported record net revenues of $3.2 million for the month of May, up 274% versus May 2019. Combined net revenues for April and May totaled $6.3 mi...

Conversion Labs ( OTCQB:CVLB ): Q1 GAAP EPS of -$0.05. More news on: Conversion Labs, Inc., Earnings news and commentary, Consumer stocks news, , Read more ...

NEW YORK, May 19, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc.  (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, reported results for the first quarter ended March 31, 2020.  Q1 2020 Financial Highlights Revenue was a record $4.3 million, up 59% ve...

NEW YORK, May 11, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc.  (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has begun the roll out of a new cloud-based, end-to-end telemedicine platform, Veritas MD . The platform builds upon Conversion Labs’ exis...

Conversion Labs ( OTCQB:CVLB +5.3% )  reported preliminary unaudited revenue of ~$4.3M, up 60% Y/Y for Q1. More news on: Conversion Labs, Inc., Consumer stocks news, , Read more ...

NEW YORK, April 21, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, reported preliminary unaudited revenue of approximately $4.3 million for the first quarter ended March 31, 2020, up 60% compared to the same year-ago p...